Magdi Elsallab

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 3

Top Topics

Acute Myeloid Leukemia

Induced Apoptosis

Top Venues

Nature biotechnology

This page only lists publications with an associated author ORCID identifier.

Publications

Magdi Elsallab, Moataz Ellithi, Matthew A Lunning, Christopher R D'Angelo, Jihyun Ma, Miguel-Ángel Perales, Matthew Frigault, Marcela V Maus
Second primary malignancies after commercial CAR T-cell therapy: analysis of the FDA Adverse Events Reporting System. Blood 143 (20) (2024)
Jonas Kath, Weijie Du, Stefania Martini, Magdi Elsallab, Clemens Franke, Laura Marie Hartmann, Vanessa Drosdek, Viktor Glaser, Maik Stein, Michael Schmueck-Henneresse, Petra Reinke, Hans-Dieter Volk, Mohamed Abou-El-Enein, Dimitrios Laurin Wagner
CAR NK-92 cell-mediated depletion of residual TCR+ cells for ultra-pure allogeneic TCR-deleted CAR T-cell products. Blood advances (2023)
Magdi Elsallab, Marcela V Maus
Expanding access to CAR T cell therapies through local manufacturing. Nature biotechnology (2023)